Exogenous Hsp70 delays senescence and improves cognitive function in aging mice

Natalia V. Bobkova,Mikhail Evgen’ev,David G. Garbuz,Alexei M. Kulikov,Alexei Morozov,Alexander Samokhin,Dmitri Velmeshev,Natalia Medvinskaya,Inna Nesterova,Andrew Pollock,Evgeny Nudler
DOI: https://doi.org/10.1073/pnas.1516131112
IF: 11.1
2015-12-14
Proceedings of the National Academy of Sciences
Abstract:Significance The compromised ability of neurons to express Heat Shock Protein 70 (Hsp70) correlates with aging-related neurodegeneration. In this study, middle-aged and old mice were treated chronically until death with human Hsp70 delivered intranasally and were investigated after 5 or 9 mo of Hsp70 treatment for their cognitive ability and synaptic density. Hsp70 treatment extended mean and maximum lifespan, improved learning and memory in old animals, increased curiosity, decreased anxiety, and helped maintain synaptic structures that degrade with age. These results provide evidence that intranasal administration of Hsp70 could have significant therapeutic potential in preserving brain tissue and memory for middle-age and old individuals and could be applied either as unique self-contained treatment or in combination with other pharmacological therapies.
multidisciplinary sciences
What problem does this paper attempt to address?